Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AtaiBeckley Inc. - Common Stock
(NQ:
ATAI
)
7.150
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AtaiBeckley Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Why AtaiBeckley Stock Soared Today
↗
July 16, 2026
The psychedelic drugmaker is being acquired.
Via
The Motley Fool
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion
↗
July 16, 2026
Today, July 16, 2026, the clinical-stage psychedelics developer jumped 33% after Lilly announced a cash deal plus milestone payments.
Via
The Motley Fool
Topics
Government
Stocks
What's going on in today's session
↗
July 16, 2026
Via
Chartmill
Curious about the most active stocks on Thursday?
↗
July 16, 2026
Via
Chartmill
Thursday's session: top gainers and losers
↗
July 16, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
July 16, 2026
Via
Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
July 16, 2026
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
July 16, 2026
Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session. The market value of their outstanding shares is at $1.9 billion. Agape ATP (NASDAQ:ATPC) shares moved...
Via
Benzinga
What This $496,000 Insider Sale at AtaiBeckley Means Amid Roughly 100% Stock Run
↗
July 09, 2026
Hershberg exercised vested options and liquidated them under a Rule 10b5-1 plan, halving direct equity while retaining 404,869 derivative securities.
Via
The Motley Fool
Topics
Regulatory Compliance
These 3 Psychedelic Stocks Activated After Trump's Executive Order
↗
April 27, 2026
Via
MarketBeat
Topics
Government
After Fifteen Years, Tim Cook Steps Down, Wall Street Steps Back, Oil Steps Up
↗
April 21, 2026
Via
Chartmill
Why AtaiBeckley Stock Surged Today
↗
April 20, 2026
President Trump wants to fast-track psychedelic research.
Via
The Motley Fool
Topics
Government
This 4/20, Wall Street Is Betting on More Than Marijuana
↗
April 20, 2026
Via
MarketBeat
AtaiBeckley Stock Skyrockets After Cantor Fitzgerald's Overweight Rating
↗
April 20, 2026
AtaiBeckley (NASDAQ:ATAI) shares are surging Monday as psychedelic biotechs rally on President Trump's executive order to fast-track reviews.
Via
Benzinga
Topics
Government
What's going on in today's session
↗
April 20, 2026
Via
Chartmill
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
↗
April 20, 2026
Trump is easing approval for psychedelic treatments for mental disorders.
Via
The Motley Fool
Topics
Government
These stocks are gapping in today's session
↗
April 20, 2026
Via
Chartmill
Top movers in Monday's pre-market session
↗
April 20, 2026
Via
Chartmill
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
March 26, 2026
Today’s Date: March 26, 2026 Introduction As the global mental health crisis reaches unprecedented levels, the pharmaceutical industry has been forced to look beyond traditional SSRIs toward more...
Via
Finterra
Topics
Cannabis
Initial Public Offering
Intellectual Property
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026
↗
January 19, 2026
Via
MarketBeat
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment
↗
January 05, 2026
GH001 showed symptom improvement, high remission rates, and sustained benefits in a Phase 2b trial for treatment-resistant depression.
Via
Stocktwits
MarketBeat’s Top 5 Rated Small-Cap Stocks
↗
December 22, 2025
Via
MarketBeat
Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order
↗
December 19, 2025
Jefferies sees restrictions around non-recreational psychedelics eventually loosen up.
Via
Stocktwits
Topics
Cannabis
ETFs
Government
Analyst Expectations For ATAI Life Sciences's Future
↗
October 22, 2025
Via
Benzinga
Why Atai Life Sciences Stock Was So Lively This Week
↗
October 17, 2025
The company, which focuses on psychedelic-based medicine, had a busy few days on both the regulatory and financing fronts.
Via
The Motley Fool
Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides
October 14, 2025
As of mid-October 2025, a compelling and diverse group of companies, spanning utilities, biotechnology, advanced materials, and defense, have seen their stocks reach impressive 52-week highs. This...
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside
↗
October 13, 2025
Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion sales by 2035.
Via
Benzinga
Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
↗
September 24, 2025
Via
Benzinga
Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews
↗
September 23, 2025
Via
Benzinga
Why Atai Life Sciences Stock Crushed It on Tuesday
↗
September 23, 2025
Investors cheered good news from the lab delivered by the company.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.